NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces it has commenced an investigation of
Immunomedics, Inc. (“Immunomedics” or “the Company”) (NASDAQ: IMMU) concerning possible violations of federal securities laws.
On December 17, 2018, FDAnews.com published an article entitled “FDA Hits Immunomedics for Data Integrity
Breach.” The article reported, in part, that “the FDA cited Immunomedics for a host of violations—including its handling of a data
integrity breach—observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.” Upon
this news, Immunomedics’ stock price fell sharply, damaging investors. To obtain additional information, go
to:
https://www.zlk.com/pslra-1/immunomedics-inc-loss-form
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The
firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
